How might infant and paediatric immune responses influence malaria vaccine efficacy?

A M Moormann1

  • 1Case Western Reserve University, Center for Global Health and Diseases, 2103 Cornell Road, WRB 4-130, Cleveland, OH 44106-7286, USA. axm109@case.edu

Parasite Immunology
|August 21, 2009
PubMed

Insights

Infants lack the immune responses needed for malaria protection, impacting vaccine efficacy. Understanding these immune deficiencies is crucial for developing effective malaria vaccines for children.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Background:

  • Naturally acquired immunity to malaria is incomplete, necessitating repeated infections and leaving infants and young children highly vulnerable to severe disease and death.
  • Infants initially receive passive protection from maternal antibodies and fetal hemoglobin, but this wanes, leaving them susceptible to diverse Plasmodium infections and uncontrolled malaria pathology.
  • The development of effective malaria vaccines targeting infants is hampered by their immature immune systems.

Purpose of the Study:

  • To review humoral, cell-mediated, and innate immune responses to malaria in infants and children.
  • To analyze how immune deficiencies in young children impact the efficacy of malaria vaccines.
  • To explore the role of regulatory immune mechanisms in developing long-lived immunity and how age affects these processes.

Main Methods:

  • Literature review of humoral, cell-mediated, and innate immunity in malaria.
  • Analysis of factors influencing infant immune responses to Plasmodium.
  • Discussion of regulatory receptors and their role in immunity and immunopathology.

Main Results:

  • Infants possess an insufficient immune repertoire to combat genetically diverse Plasmodium infections effectively.
  • Deficiencies in infant immune responses may significantly influence the efficacy of malaria vaccines in this critical age group.
  • The precise influence of age and malaria infection on immune regulatory receptors remains largely unknown.

Conclusions:

  • Infants may struggle to balance parasite clearance with immune regulation, hindering the development of protective immunological memory.
  • Malaria vaccines tested in adults may not accurately predict efficacy in infant populations.
  • Further research is needed to understand age-specific immune responses for improved malaria vaccine development in children.

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccinations01:51

Vaccinations

Overview
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...